Targeting metabolic diseases: the role of nutraceuticals in modulating oxidative stress and inflammation
The escalating prevalence of metabolic and cardiometabolic disorders, often characterized
by oxidative stress and chronic inflammation, poses significant health challenges globally …
by oxidative stress and chronic inflammation, poses significant health challenges globally …
[HTML][HTML] Cardiovascular implications of inflammatory bowel disease: an updated review
A Bhardwaj, A Singh, V Midha, A Sood… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Emerging data highlights the heightened risk of atherosclerotic cardiovascular diseases
(ASCVD) in patients with chronic inflammatory disorders, particularly those afflicted with …
(ASCVD) in patients with chronic inflammatory disorders, particularly those afflicted with …
[HTML][HTML] Astaxanthin attenuates cigarette smoking-induced oxidative stress and inflammation in a sirtuin 1-dependent manner
M Deng, R Tong, Y Bian, G Hou - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Oxidative stress and chronic inflammation play key roles in the pathogenesis of chronic
obstructive pulmonary disease (COPD). Astaxanthin (AXT) is a keto-carotenoid with a variety …
obstructive pulmonary disease (COPD). Astaxanthin (AXT) is a keto-carotenoid with a variety …
Exploring the correlation between systemic inflammatory markers and carotid atherosclerosis indices in middle-aged adults: a cross-sectional study
JE Song, JI Hwang, HJ Ko, JY Park, HE Hong… - Journal of …, 2024 - mdpi.com
Background: This study investigated the association between atherosclerosis and systemic
inflammation markers, specifically the C-reactive protein (CRP), erythrocyte sedimentation …
inflammation markers, specifically the C-reactive protein (CRP), erythrocyte sedimentation …
Mild phototherapy mediated by IR780-Gd-OPN nanomicelles suppresses atherosclerotic plaque progression through the activation of the HSP27-regulated NF-κB …
W He, S Tu, J Han, H Cui, L Lai, Y Ye, T Dai, Y Yuan… - Acta Biomaterialia, 2024 - Elsevier
Reducing plaque lipid content and enhancing plaque stability without causing extensive
apoptosis of foam cells are ideal requirements for developing a safe and effective treatment …
apoptosis of foam cells are ideal requirements for developing a safe and effective treatment …
Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control project
G Sun, C Wang, N Ye, C Shi, N Ouyang, L Qiao, G Li… - BMC medicine, 2024 - Springer
Abstract Background The 2018/2023 ESC/ESH Guidelines underlined a gap how baseline
cardiovascular disease (CVD) risk predicted blood pressure (BP) lowering benefits. Further …
cardiovascular disease (CVD) risk predicted blood pressure (BP) lowering benefits. Further …
[HTML][HTML] Association between sarcopenia and multimorbidity among middle-aged and older adults in China: Findings from the China Health and Retirement …
M Deng, Y Lu, X Li, X Zhou, G Hou - Experimental Gerontology, 2024 - Elsevier
Background Little is known about the association between sarcopenia and multimorbidity
among middle-aged and older adults. This study investigated whether sarcopenia is …
among middle-aged and older adults. This study investigated whether sarcopenia is …
Immuno-modulatory role of baicalin in atherosclerosis prevention and treatment: current scenario and future directions
L Wang, S Huang, X Liang, J Zhou, Y Han… - Frontiers in …, 2024 - frontiersin.org
Atherosclerosis (AS) is recognized as a chronic inflammatory condition characterized by the
accumulation of lipids and inflammatory cells within the damaged walls of arterial vessels. It …
accumulation of lipids and inflammatory cells within the damaged walls of arterial vessels. It …
[HTML][HTML] Unravelling the Impact of RNA Methylation Genetic and Epigenetic Machinery in the Treatment of Cardiomyopathy
L Liu, L Yu, Y Wang, L Zhou, Y Liu, X Pan… - Pharmacological …, 2024 - Elsevier
Cardiomyopathy (CM) represents a heterogeneous group of diseases primarily affecting
cardiac structure and function, with genetic and epigenetic dysregulation playing a pivotal …
cardiac structure and function, with genetic and epigenetic dysregulation playing a pivotal …
Berberine ameliorates diabetic cardiomyopathy in mice by decreasing cardiomyocyte apoptosis and oxidative stress
X Sun, Z Li, L Wang, Y Wang, C Lu - Cardiovascular Innovations …, 2023 - scienceopen.com
Background: Diabetic cardiomyopathy is a multifaceted complication of diabetes that lacks
effective treatments. Berberine (BBR), a bioactive compound from Rhizoma coptidis, has …
effective treatments. Berberine (BBR), a bioactive compound from Rhizoma coptidis, has …